[Virus factors determining the outcome of IFN treatment for chronic hepatitis C]

Nihon Rinsho. 2004 Jul;62 Suppl 7(Pt 1):474-80.

[Article in Japanese]

Authors

Nobuhiko Kanazawa¹, Mina Nakagawa, Hideki Watanabe, Naoya Sakamoto, Nobuyuki Enomoto

Affiliation

¹ Department of Gastroenterology and Hepatology, School of Medicine, Tokyo Medical and Dental University.

PMID: 15359844

No abstract available

Publication types

Review

MeSH terms

Antiviral Agents / therapeutic use*
Drug Resistance, Viral / genetics
Drug Therapy, Combination
Genotype
Hepacivirus / genetics*
Hepatitis C / drug therapy*
Hepatitis C / virology*
Humans
Interferons / therapeutic use*
Mutation
Ribavirin / therapeutic use
Treatment Outcome
Viral Envelope Proteins / genetics
Viral Nonstructural Proteins / genetics
Viral Proteins / genetics

Substances

Antiviral Agents
HVR1 protein, Hepatitis C virus
Viral Envelope Proteins
Viral Nonstructural Proteins
Viral Proteins
glycoprotein E2, Hepatitis C virus
Ribavirin
Interferons
NS-5 protein, hepatitis C virus